Stephen Russell

Stephen Russell

Company: Vyriad, Inc.

Job title: Chief Executive Officer


Intravenous Administration of an Oncolytic Vesicular Stomatitis Virus: Clinical Experience to Date 9:00 am

Voyager V1 has been administered intravenously to over 100 cancer patients in clinical trials Compelling evidence of single agent activity after a single infusion will be presentedRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.